We are live on ! Find out more
TCBP

TC BioPharm (Holdings) plc American Depositary Shares

Delisted

TCBP was delisted on the 21st of March, 2025.

7 hedge funds and large institutions have $48.9K invested in TC BioPharm (Holdings) plc American Depositary Shares in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

17% more funds holding

Funds holding: 67 (+1)

36% less capital invested

Capital invested by funds: $77K → $48.9K (-$28.1K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change

TCBP Hedge Fund Activity: Q3 2024 in Review

7 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc American Depositary Shares (TCBP) for Q3 2024, worth a combined $48.9K — down 36% from $77K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new TCBP positions and 4 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was FNY Investment Advisers, opening a new position worth an estimated $52.2K. The largest seller was Platform Technology Partners, exiting entirely with an estimated $41.2K sold.

  • 7 institutional investors held TC BioPharm (Holdings) plc American Depositary Shares (TCBP) as of Q3 2024, up from 6 in Q2 2024.
  • Funds reported $48.9K of TC BioPharm (Holdings) plc American Depositary Shares stock for Q3 2024, down 36% quarter-over-quarter.
  • 5 funds opened new TC BioPharm (Holdings) plc American Depositary Shares positions in Q3 2024 and 4 closed out, a net change of +1 holder.
  • The largest TC BioPharm (Holdings) plc American Depositary Shares buyer in Q3 2024 was FNY Investment Advisers, an estimated $52.2K added.
  • The largest TC BioPharm (Holdings) plc American Depositary Shares seller in Q3 2024 was Platform Technology Partners, an estimated $41.2K sold.

Based on aggregated 13F filings for Q3 2024.